5am Partners VII, LLC sells $140,313 of Skye Bioscience stock

5AM Partners VII, LLC, a major shareholder in Skye Bioscience, Inc., reported the sale of $140,313 worth of the company's stock between August 18 and August 20, 2026. The company, which owns 10% of Skye Bioscience, sold the shares at prices between $0.32 and $0.38 per share. Transactions were completed on August 18, 19, and 20, 2026, with shares sold by 5AM Ventures II, L.P., 5AM Co-Investors II, L.P., and 5AM Ventures VII, L.P.

The total number of shares sold across these dates was 141,000. As of August 20, 2026, the firm's ownership of Skye Bioscience shares stood at 1,400,560, 55,208, and 7,850,155 for 5AM Ventures II, L.P., 5AM Co-Investors II, L.P., and 5AM Ventures VII, L.P., respectively. The insider sales occur at a time when Skye Bioscience's stock has faced recent pressure, with the company's stock taking a significant hit over the past week, as indicated by the Relative Strength Index (RSI) suggesting it is in oversold territory.

The company has also received a notice from the Nasdaq Stock Market LLC regarding non-compliance with the equity listing rule due to a negative stockholders’ equity of $497,307 as of June 30, 2026, below the required minimum of $2.5 million.